Potent/JJ
gene/NN
regulatory/JJ
and/CC
antiproliferative/JJ
activities/NNS
of/IN
20-methyl/JJ
analogues/NNS
of/IN
1,25/CD
dihydroxyvitamin/NN
D3/NN
./.

The/DT
biological/JJ
active/JJ
form/NN
of/IN
vitamin/NN
D3/NN
,/,
1,25-dihydroxyvitamin/NN
D3/NN
(/(
VD/NN
)/)
,/,
regulates/VBZ
cellular/JJ
growth/NN
and/CC
differentiation/NN
./.
=====
This/DT
provides/VBZ
the/DT
hormone/NN
with/IN
an/DT
interesting/JJ
therapeutic/JJ
potential/NN
./.
=====
However/RB
,/,
hypercalcemia/NN
is/VBZ
a/DT
side/JJ
effect/NN
,/,
which/WDT
is/VBZ
caused/VBN
by/IN
VD/NN
's/POS
classical/JJ
action/NN
,/,
the/DT
regulation/NN
of/IN
calcium/NN
homeostasis/NN
./.
=====
This/DT
made/VBD
the/DT
need/NN
for/IN
VD/NN
analogues/NNS
with/IN
selectively/RB
increased/VBN
cell/NN
regulatory/JJ
properties/NNS
./.
=====
Studies/NNS
with/IN
20-epi/JJ|NN
analogues/NNS
pointed/VBD
out/RP
the/DT
importance/NN
of/IN
the/DT
carbon-20/NN
position/NN
and/CC
led/VBD
to/TO
the/DT
development/NN
of/IN
20-methyl/NN
derivatives/NNS
of/IN
VD/NN
./.
=====
In/IN
this/DT
report/NN
the/DT
biological/JJ
properties/NNS
of/IN
the/DT
compounds/NNS
ZK161422/NN
and/CC
ZK157202/NN
,/,
which/WDT
are/VBP
20-methyl-/NN
and/CC
20-methyl-23-eneanalogues/NN
,/,
respectively/RB
,/,
have/VBP
been/VBN
analyzed/VBN
in/IN
comparison/NN
with/IN
VD/NN
./.
=====
Both/DT
compounds/NNS
show/VBP
about/IN
2-fold/RB
lower/JJR
affinity/NN
to/TO
the/DT
VD/NN
receptor/NN
(/(
VDR/NN
)/)
than/IN
VD/NN
./.
=====
However/RB
,/,
compared/VBN
to/TO
VD/NN
,/,
their/PRP$
antiproliferative/JJ
effect/NN
is/VBZ
up/RB
to/TO
30-fold/RB
higher/JJR
on/IN
human/JJ
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
and/CC
even/RB
up/RB
to/TO
300-fold/RB
higher/JJR
on/IN
human/JJ
breast/NN
cancer/NN
MCF-7/NN
cells/NNS
./.
=====
Whereas/IN
the/DT
hypercalcemic/JJ
effect/NN
for/IN
ZK157202/NN
is/VBZ
also/RB
increased/VBN
10-fold/RB
,/,
ZK161422/NN
has/VBZ
the/DT
same/JJ
calcium-mobilizing/JJ
potency/NN
as/IN
VD/NN
./.
=====
Moreover/RB
,/,
ZK161422/NN
,/,
but/CC
not/RB
ZK157202/NN
,/,
showed/VBD
preference/NN
for/IN
gene/NN
activation/NN
from/IN
a/DT
promoter/NN
carrying/VBG
a/DT
VD/NN
response/NN
element/NN
with/IN
a/DT
palindromic/JJ
arrangement/NN
of/IN
two/CD
hexameric/JJ
receptor/NN
binding/NN
sites/NNS
spaced/VBN
by/IN
9/CD
nucleotides/NNS
(/(
IP9/NN
)/)
rather/RB
than/IN
for/IN
activation/NN
from/IN
a/DT
response/NN
element/NN
formed/VBN
by/IN
a/DT
direct/JJ
repeat/NN
spaced/VBN
by/IN
3/CD
nucleotides/NNS
(/(
DR3/NN
)/)
./.
=====
This/DT
observation/NN
supports/VBZ
a/DT
model/NN
,/,
in/IN
which/WDT
promoter/NN
selectivity/NN
reflects/VBZ
the/DT
selectively/RB
increased/VBN
antiproliferative/JJ
effect/NN
of/IN
VD/NN
analogues/NNS
./.